I think these shares could have inflation-beating dividends: Centrica PLC, AstraZeneca plc, HSBC Holdings plc and Royal Dutch Shell Plc

Here’s why I think these shares may have dividend investment appeal: Centrica PLC (LON:CNA) (CNA.L), AstraZeneca plc (LON:AZN) (AZN.L), HSBC Holdings plc (LON:HSBA) (HSBA.L) and Royal Dutch Shell Plc (LON:RDSB) (RDSB.L)

HSBC Holdings plc
HSBC Holdings plc

With inflation rising to 2.9% last month, I’m taking a closer look at the dividend prospects of Centrica PLC (LON:CNA) (CNA.L), AstraZeneca plc (LON:AZN) (AZN.L), HSBC Holdings plc (LON:HSBA) (HSBA.L) and Royal Dutch Shell Plc (LON:RDSB) (RDSB.L).

Centrica has been a popular income stock for many years. I think this could increase in future as the company moves away from oil and gas activities and towards energy supply and management. I feel a more resilient business model could be on offer which makes dividend payments more predictable. With a dividend yield of 6.3% and the potential for higher profitability from cost saving measures, I’m upbeat about Centrica’s income prospects.

Shell is one of my favourite income shares at the moment. Its 6.4% yield is one of the highest I can find among large-cap shares, and with the company’s free cash flow forecast to rise I believe dividends could move higher. Sure, there is a risk from a lower oil price, but with Shell having a strong balance sheet in my view I feel it could perform well in the long run.

AstraZeneca is a company experiencing some difficulties with the loss of patents. However, it has been able to make several important acquisitions in the last few years which I feel have strengthened its profit growth potential. I like the company’s defensive qualities and feel AstraZeneca’s dividend yield of 4.3% is appealing given its long term growth prospects.

HSBC offers a dividend yield of 5.2% at the moment. Compared to some of its banking peers, that is relatively high just now. I believe the bank’s exposure to Asia could set it apart from some of its peers, since demand for financial products is likely to increase as wealth levels rise. HSBC has a solid position in a number of key Asian markets and alongside cost savings, I feel it is well-placed to be a strong dividend stock in the long term.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.